Apollo Endosurgery, Inc. APEN

Full chart Compare
Set alert

Price alert · APEN

All alert types
10.00 0.00 (+0.00%)

At closeApr 3, 2023, 4:00 PM EDT

9.92 Day range 10.00

52-week range unavailable

Analyst view

Consensus: buy

Buy
Price target (mean) 10.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 5
  • 2 months ago 5
  • 3 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

APEN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.21-0.23 – -0.20-0.210.0%19.73M+18.4%2
Next quarter-0.21-0.22 – -0.21-0.26+19.2%22.64M+17.3%2
Current year-0.83-0.84 – -0.82-0.98+15.3%89.48M+16.4%2
Next year-0.88-0.88 – -0.88-0.83-6.0%116.68M+30.4%1

Upgrades and downgrades

The latest rating changes

APEN analyst upgrades and downgrades
DateFirmActionFromTo
Jan 23, 2023Cowen & Co.DowngradeOutperformMarket Perform
Jan 4, 2023StifelDowngradeBuyHold
Nov 30, 2022Lake StreetDowngradeBuyHold
May 4, 2022Stephens & Co.Maintained—Overweight
Feb 23, 2022StifelMaintained—Buy
Dec 15, 2021Cowen & Co.Initiated—Outperform
Dec 9, 2021StifelInitiated—Buy
Sep 9, 2021Stephens & Co.Initiated—Overweight
Jun 14, 2021Piper SandlerMaintained—Overweight
May 17, 2021Lake StreetInitiated—Buy
Nov 30, 2020Piper SandlerUpgradeNeutralOverweight
Apr 28, 2020Piper SandlerDowngradeOverweightNeutral
Mar 27, 2020Piper SandlerMaintained—Overweight
Nov 9, 2018Northland SecuritiesDowngradeMarket PerformUnderperform
Jul 17, 2018Roth CapitalDowngradeBuyNeutral
Apr 13, 2018PiperJaffrayInitiated—Overweight
Sep 26, 2017Northland SecuritiesInitiated—Outperform
Aug 2, 2017Roth CapitalInitiated—Buy
Jul 24, 2017Craig-HallumInitiated—Buy